Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Saturday, August 02, 2014
 Services
Submit a manuscript
Subscribe
Individuals
Institutions
Response
Send response
Read responses
Reprint
Advance online publication
Sign up for e-alert
JCIM job opportunities
Contact JCIM
 Information For
Readers
Authors
Reviewers
Advertisers
 About JCIM
Journal description
Editorial policy
Privacy policy
Copy right
Editorial staff
 Language Polishing
Journal of Chinese Integrative Medicine: 2009; 7(9): 889-896
DOI: 10.3736/jcim20090918
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition)
1. David Moher (Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada E-mail: dmoher@ohri.ca)
2. Alessandro Liberat (Università di Modena e Reggio Emilia, Modena, Italy )
3. Jennifer Tetzlaff (Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada )
4. Douglas G. Altman (Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom )
5. The PRISMA Group (- )
Welcome to JCIM! You are the number 6581 reader of this article!
Download Article:
[Full Text]      [PDF]      [Chinese]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Moher D, Liberat A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition). J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2009; 7(9): 889-896.
References:
1Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature. Ⅵ. How to use an overview. Evidence-Based Medicine Working Group[J].JAMA, 1994, 272(17): 1367-1371.  .
2Swingler GH, Volmink J, Ioannidis JP. Number of published systematic reviews and global burden of disease: Database analysis[J].BMJ, 2003, 327(7423): 1083-1084.  .
3Canadian Institutes of Health Research. Randomized controlled trials registration/application checklist (12/2006)[2009-05-19]. http://www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf.
4Young C, Horton R. Putting clinical trials into context[J].Lancet, 2005, 366(9480): 107-108.  .
5Mulrow CD. The medical review article: state of the science[J].Ann Intern Med, 1987, 106(3): 485-488.  .
6Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analysis of randomized controlled trials[J].New Engl J Med, 1987, 316(8): 450-455.  .
7Sacks HS, Reitman D, Pagano D, Kupelnick B. Meta-analysis: an update[J].Mt Sinai J Med, 1996, 63(3-4): 216-224.  .
8Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reporting of meta-analysis of randomized controlled trials: The QUOROM statement[J].Lancet, 1994, 354(9193): 1896-1900.  .
9Green S, Higgins J. Glossary. Cochrane handbook for systematic reviews of interventions 4.2.5. The Cochrane Collaboration [2009-05-19]. http://www.cochrane.org/resources/glossary.htm.
10Strech D, Tilburt J. Value judgments in the analysis and synthesis of evidence[J].J Clin Epidemiol, 2008, 61(6): 521-524.  .
11Moher D, Tsertsvadze A. Systematic reviews: when is an update an update?[J].Lancet, 2006, 367(9514): 881-883.  .
12University of York. Centre for Reviews and Dissemination [2009-05-19]. http://www.york.ac.uk/inst/crd/.
13The Joanna Briggs Institute. Protocols & work in progress [2009-05-19]. http://www.joannabriggs.edu.au/pubs/systematic_reviews_prot.php.
14De Angelis C, Drazan JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB; International Committee of Medical Journal Editors. Systematic reviews: when is an update an update?Clinical trial registration: a statement from the International Committee of Medical Journal Editors[J].CMAJ, 2004, 171(6): 606-607.  .
15Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data[J].Lancet, 2004, 363(9418): 1341-1345.  .
16Bagshaw SM, McAlister FA, Manns BJ, Ghali WA. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence[J].Arch Intern Med, 2006, 166(2): 161-166.  .
17Biondi-Zoccai GG, Lotrionte M, Abbate A, Testa L, Remigi E, Burzotta F, Valgimigli M, Romagnoli E, Crea F, Agostoni P. Compliance with QUOROM and quality of reporting of overlapping meta analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study[J].BMJ, 2006, 332(7535): 202-209.  .
18Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration[J].PLoS Med, 2009, 6(7): e1000100.  .
19Altman DG, Schulz KR, Moher D, Egger M, Davidoff F, Elbourne D, Gtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration[J].Ann Intern Med, 2001, 134(8): 663-694.  .
20Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD explanation and elaboration[J].Ann Intern Med, 2003, 138(1): W1-W12.  .
21Vandenbroucke JP, von Elm E, Altman DG, Gtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration[J].Ann Intern Med, 2007, 147(8): W163-W194.  .
22Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews[J].PLoS Med, 2007, 4(3): e78.  .
23Bhandari M, Morrow F, Kulkarni AV, Tornetta P 3rd. Meta-analyses in orthopaedic surgery: a systematic review of their methodologies[J].J Bone Joint Surg Am, 2001, 83-A(1): 15-24.  .
24Kelly KD, Travers A, Dorgan M, Slater L, Rowe BH. Evaluating the quality of systematic reviews in the emergency medicine literature[J].Ann Emerg Med, 2001, 38(5): 518-526.  .
25Richards D. The quality of systematic reviews in dentistry[J].Evid Based Dent, 2004, 5(1): 17.  .
26Choi PT, Halpern SH, Malik N, Jadad AR, Tramr MR, Walder B. Examining the evidence in anesthesia literature: a critical appraisal of systematic reviews[J].Anesth Analg, 2001, 92(3): 700-709.  .
27Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB, Doig CJ. A systematic evaluation of the quality of meta-analyses in the critical care literature[J].Crit Care, 2005, 9(5): R575-R582.  .
28Dickersin K. Publication bias: recognizing the problem, understanding its origins and scope, and preventing harm. In: Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis-prevention, assessment and adjustments. Chichester (UK): John Wiley & Sons. 2005: 11-33.
29Sutton AJ. Evidence concerning the consequences of publication and related biases. In: Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis prevention, assessment and adjustments. Chichester (UK): John Wiley & Sons. 2005: 175-192.
30Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot[J].BMJ, 2006, 333(7568): 597-600.  .
31Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis[J].Ann Intern Med, 2001, 135(9): 769-781.  .
32Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests[J].BMJ, 2001, 323(7305): 157-162.  .
33Altman DG. Systematic reviews of evaluations of prognostic variables[J].BMJ, 2001, 323(7306): 224-228.  .
34Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies[J].Nat Genet, 2001, 29(3): 306-309.  .
35Lavis J, Davies H, Oxman A, Denis J, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform health care management and policy-making[J].J Health Serv Res Policy, 2005, 10(Suppl 1): 35-48.  .
36Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group[J].Stat Med, 1995, 14(19): 2057-2079.  .
37Moja LP, Telaro E, D’Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: Results of the meta quality cross sectional study[J].BMJ, 2005, 330(7499): 1053.  .
38Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ, 2005, 336(7650): 924-926.  .
39Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, Manthous CA, Maurer JR, McNicholas WT, Oxman AD, Rubenfeld G, Turino GM, Guyatt G; ATS Documents Development and Implementation Committee. An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations[J].Am J Respir Crit Care Med, 2006, 174(5): 605-614.  .
40Chan AW, Hrobjartsson A, Haahr MT, Gtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles[J].JAMA, 2004, 291(20): 2457-2465.  .
41Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research[J].CMAJ, 2004, 171(7): 735-740.  .
42Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: Comparing what was done to what was planned[J].JAMA, 2002, 287(151): 2831-2834.  .

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977